<?properties open_access?>
<?DTDIdentifier.IdentifierValue -//NLM//DTD Journal Publishing DTD v2.3 20070202//EN?>
<?DTDIdentifier.IdentifierType public?>
<?SourceDTD.DTDName journalpublishing.dtd?>
<?SourceDTD.Version 2.3?>
<?ConverterInfo.XSLTName jp2nlmx2.xsl?>
<?ConverterInfo.Version 2?>
<front>
  <journal-meta>
    <journal-id journal-id-type="nlm-ta">Nucleic Acids Res</journal-id>
    <journal-id journal-id-type="iso-abbrev">Nucleic Acids Res</journal-id>
    <journal-id journal-id-type="publisher-id">nar</journal-id>
    <journal-id journal-id-type="hwp">nar</journal-id>
    <journal-title-group>
      <journal-title>Nucleic Acids Research</journal-title>
    </journal-title-group>
    <issn pub-type="ppub">0305-1048</issn>
    <issn pub-type="epub">1362-4962</issn>
    <publisher>
      <publisher-name>Oxford University Press</publisher-name>
    </publisher>
  </journal-meta>
  <article-meta>
    <article-id pub-id-type="pmcid">3394289</article-id>
    <article-id pub-id-type="pmid">22675071</article-id>
    <article-id pub-id-type="doi">10.1093/nar/gks480</article-id>
    <article-id pub-id-type="publisher-id">gks480</article-id>
    <article-categories>
      <subj-group subj-group-type="heading">
        <subject>Articles</subject>
      </subj-group>
    </article-categories>
    <title-group>
      <article-title>Paratome: an online tool for systematic identification of antigen-binding regions in antibodies based on sequence or structure</article-title>
    </title-group>
    <contrib-group>
      <contrib contrib-type="author">
        <name>
          <surname>Kunik</surname>
          <given-names>Vered</given-names>
        </name>
      </contrib>
      <contrib contrib-type="author">
        <name>
          <surname>Ashkenazi</surname>
          <given-names>Shaul</given-names>
        </name>
      </contrib>
      <contrib contrib-type="author">
        <name>
          <surname>Ofran</surname>
          <given-names>Yanay</given-names>
        </name>
        <xref ref-type="corresp" rid="gks480-COR1">*</xref>
      </contrib>
    </contrib-group>
    <aff>The Goodman Faculty of Life Sciences, Nanotechnology Building, Bar-Ilan University, Ramat Gan 52900, Israel</aff>
    <author-notes>
      <corresp id="gks480-COR1">*To whom correspondence should be addressed. Tel: <phone>+972 3 531 9772</phone>; Fax: <fax>+972 3 7384197</fax>; Email: <email>yanay@ofranlab.org</email></corresp>
    </author-notes>
    <!--For NAR both ppub and collection dates generated for PMC processing 1/27/05 beck-->
    <pub-date pub-type="collection">
      <month>7</month>
      <year>2012</year>
    </pub-date>
    <pub-date pub-type="ppub">
      <month>7</month>
      <year>2012</year>
    </pub-date>
    <pub-date pub-type="epub">
      <day>6</day>
      <month>6</month>
      <year>2012</year>
    </pub-date>
    <pub-date pub-type="pmc-release">
      <day>6</day>
      <month>6</month>
      <year>2012</year>
    </pub-date>
    <!-- PMC Release delay is 0 months and 0 days and was based on the
							<pub-date pub-type="epub"/>. -->
    <volume>40</volume>
    <issue>Web Server issue</issue>
    <fpage>W521</fpage>
    <lpage>W524</lpage>
    <history>
      <date date-type="received">
        <day>2</day>
        <month>2</month>
        <year>2012</year>
      </date>
      <date date-type="rev-recd">
        <day>26</day>
        <month>4</month>
        <year>2012</year>
      </date>
      <date date-type="accepted">
        <day>8</day>
        <month>5</month>
        <year>2012</year>
      </date>
    </history>
    <permissions>
      <copyright-statement>© The Author(s) 2012. Published by Oxford University Press.</copyright-statement>
      <copyright-year>2012</copyright-year>
      <license license-type="creative-commons" xlink:href="http://creativecommons.org/licenses/by-nc/3.0">
        <license-p><!--CREATIVE COMMONS-->This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (<ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by-nc/3.0">http://creativecommons.org/licenses/by-nc/3.0</ext-link>), which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.</license-p>
      </license>
    </permissions>
    <abstract>
      <p>Antibodies are capable of specifically recognizing and binding antigens. Identification of the antigen-binding site, commonly dubbed paratope, is of high importance both for medical and biological applications. To date, the identification of antigen-binding regions (ABRs) relies on tools for the identification of complementarity-determining regions (CDRs). However, we have shown that up to 22% of the residues that actually bind the antigen fall outside the traditionally defined CDRs. The Paratome web server predicts the ABRs of an antibody, given its amino acid sequence or 3D structure. It is based on a set of consensus regions derived from a structural alignment of a non-redundant set of all known antibody–antigen complexes. Given a query sequence or structure, the server identifies the regions in the query antibody that correspond to the consensus ABRs. An independent set of antibody–antigen complexes was used to test the server and it was shown to correctly identify at least 94% of the antigen-binding residues. The Paratome web server is freely available at <ext-link ext-link-type="uri" xlink:href="http://www.ofranlab.org/paratome/">http://www.ofranlab.org/paratome/</ext-link>.</p>
    </abstract>
    <counts>
      <page-count count="4"/>
    </counts>
  </article-meta>
</front>
<body>
  <sec>
    <title>INTRODUCTION</title>
    <p>One of the most common problems in immunological research is the identification of paratopes, namely the residues within an immunoglobulin that recognize and bind the antigen (Ag). The high affinity and specificity of antibodies (Abs) to their cognate Ag, which allows them to block its activity or to mark it for destruction (<xref ref-type="bibr" rid="gks480-B1">1</xref>), are at the heart of immunity. They also make Abs powerful tools in numerous molecular applications in research as well as in diagnostics and therapy (<xref ref-type="bibr" rid="gks480-B2 gks480-B3 gks480-B4 gks480-B5 gks480-B6 gks480-B7">2–7</xref>). Therefore, to understand immunity (and autoimmunity) and to engineer and improve Ab-based applications, one needs to first identify the molecular determinants that mediate Ag recognition and binding. However, currently there is no tool available for providing such prediction. complementarity-determining regions (CDRs) are considered a proxy for the sites that recognize and bind the Ag. CDRs are six hypervariable segments of amino acids, three on each of the light and heavy chains (<xref ref-type="bibr" rid="gks480-B8 gks480-B9 gks480-B10">8–10</xref>).</p>
    <p>Attempts to computationally identify CDRs have been on going for &gt;40 years (<xref ref-type="bibr" rid="gks480-B10 gks480-B11 gks480-B12 gks480-B13 gks480-B14 gks480-B15 gks480-B16 gks480-B17">10–17</xref>). The most commonly used CDR identification methods to date are Kabat (<xref ref-type="bibr" rid="gks480-B10">10</xref>,<xref ref-type="bibr" rid="gks480-B15">15</xref>), Chothia (<xref ref-type="bibr" rid="gks480-B12">12</xref>,<xref ref-type="bibr" rid="gks480-B13">13</xref>,<xref ref-type="bibr" rid="gks480-B16">16</xref>) and IMGT (<xref ref-type="bibr" rid="gks480-B16">16</xref>). Each of these methods has devised a unique residue numbering scheme according to which it numbers the hypervariable region residues and the beginning and ending of each of the six CDRs is then determined according to certain key positions. The pressing need in this type of analysis is manifested in the citations: in 2010 alone these methods generated over 500 citations. Arguably, many of the users are not interested in the CDRs as such but rather are interested in identifying the residues that mediate Ag binding. However, in a recent analysis we have shown that CDR identification methods may miss &gt;20% of the residues that actually bind the Ag (<xref ref-type="bibr" rid="gks480-B18">18</xref>). Furthermore, we have also shown that the residues that are missed by these methods include some that make crucial energetic contribution to Ag binding (<xref ref-type="bibr" rid="gks480-B18">18</xref>).</p>
    <p>The Paratome web server implements an algorithm we developed for the identification of antigen-binding regions (ABRs) from the amino acid sequence or 3D structure of an Ab (<xref ref-type="bibr" rid="gks480-B18">18</xref>). The algorithm is based on the premise that the vast majority of antigen-binding residues lie in regions of structural consensus between Abs. These structural consensus regions form six sequence stretches along the Ab sequence, roughly corresponding to the six CDRs (<xref ref-type="bibr" rid="gks480-B18">18</xref>,<xref ref-type="bibr" rid="gks480-B19">19</xref>). The server uses the structural consensus regions within a multiple structure alignment (MSTA) of a non-redundant set of all antibody–antigen (Ab–Ag) complexes, as a reference according to which the ABRs of unannotated Abs are inferred (<xref ref-type="bibr" rid="gks480-B18">18</xref>). It is trained to identify binding regions for Abs that bind protein or peptide Ags. To our knowledge, Paratome is currently the only server aimed at identifying the Ag-binding site of Abs, which can then be used as starting points for experiments, may help improve vaccine and Ab design and may serve for large scale analysis of Abs.</p>
  </sec>
  <sec>
    <title>DESCRIPTION OF WEB SERVER</title>
    <sec>
      <title>Input</title>
      <p>The input for the Paratome web server is either an amino acid sequence or a 3D structure (or PDB id) of an Ab. 3D structures must be in PDB file format (<ext-link ext-link-type="uri" xlink:href="http://www.wwpdb.org/docs.html">http://www.wwpdb.org/docs.html</ext-link>, 23 May 2012, date last accessed). Analysis of multiple Abs is available by uploading a compressed file containing a collection of either sequences or structures. Each submission allows the analysis of up to 100 MB of sequences or structures. Processing time is typically 5–15 s per query Ab.</p>
    </sec>
    <sec>
      <title>Output</title>
      <p>The first analysis done by the server determines whether the input includes an Ab or a fragment thereof. If the input is not identified as such, the results page includes a link to a text files in which this result is stated and explained (e.g. no BLAST hits found, see <ext-link ext-link-type="uri" xlink:href="http://nar.oxfordjournals.org/cgi/content/full/gks480/DC1">Supplementary Data S1C</ext-link>). Otherwise, the results page links to two files—a text file and an HTML file. These files provide a list of the residues that make up each ABR and their location. The HTML file provides also visualization of the ABRs highlighted in the sequence of the query Ab. For sequences, ABRs location is indicated according to their sequence position within the query sequence (see <ext-link ext-link-type="uri" xlink:href="http://nar.oxfordjournals.org/cgi/content/full/gks480/DC1">Supplementary Data S1A</ext-link> and <ext-link ext-link-type="uri" xlink:href="http://nar.oxfordjournals.org/cgi/content/full/gks480/DC1">S1B</ext-link>). <xref ref-type="fig" rid="gks480-F1">Figure 1</xref> shows the HTML results file of running Paratome on the structure of anti-IL-15 (PDB id 2xqb). For 3D structures, the location of each residue within the predicted ABRs is indicated according to its residue number as it appears in the input PDB (<xref ref-type="fig" rid="gks480-F1">Figure 1</xref>A). Disordered ABRs residues (i.e. residues missing from the ATOM field) are marked with an asterisk (<xref ref-type="fig" rid="gks480-F1">Figure 1</xref>A). Additionally, the structure of the query Ab with its predicted ABRs highlighted is accessible using the Jmol Java applet (<xref ref-type="fig" rid="gks480-F1">Figure 1</xref>B).
<fig id="gks480-F1" position="float"><label>Figure 1.</label><caption><p>An example HTML results file of running Paratome on anti IL-15 (PDB id 2xqb). (<bold>A</bold>) The sequences of Ab chains with ABRs highlighted. The location of ABRs residues is indicated according to the numbering in the ATOM field within the input PDB file. Note that for ABR L1, the location of five residues (S, N, L, K and R) is indicated with an asterisk as they do not appear in the ATOM field within the PDB file. A link to the visualization of the analyzed complex is located below the list of identified ABRs. (<bold>B</bold>) The visualization of the analyzed 2qxb complex using the Jmol Java applet.</p></caption><graphic xlink:href="gks480f1"/></fig></p>
    </sec>
  </sec>
  <sec sec-type="materials|methods">
    <title>MATERIALS AND METHODS</title>
    <sec>
      <title>ABRs identification</title>
      <p>Paratome is based on a large MSTA of Abs, which revealed regions of structural consensus where the pattern of structural positions that bind the Ag is highly similar among all known Abs. These consensus regions, we found, cover virtually all the residues that bind the Ag. The algorithm is based on the fact that for each Ab in the MSTA we have already identified the ABRs. Thus, given a query Ab, the algorithm performs three consecutive steps: (i) A BLAST (<xref ref-type="bibr" rid="gks480-B20">20</xref>) search against all the sequences in the MSTA. If the query is a PDB file, the sequence is extracted from the SEQRES field (if exists). Otherwise, it is extracted from the ATOM field. (ii) Next, a pairwise alignment is performed between the query Ab and the top BLAST hit: If the input is a sequence, each framework region (FR) of the top BLAST hit Ab is locally aligned to the query Ab using the Smith–Waterman local alignment algorithm (<xref ref-type="bibr" rid="gks480-B21">21</xref>). For a detailed example of sequence-based FRs pairwise alignment, see <ext-link ext-link-type="uri" xlink:href="http://nar.oxfordjournals.org/cgi/content/full/gks480/DC1">Supplementary Data S2</ext-link>. If the input is an Ab 3D structure, the best BLAST hit Ab and the query Ab are structurally aligned using the combinatorial extension (CE) structural alignment algorithm (<xref ref-type="bibr" rid="gks480-B22">22</xref>). For a detailed example of Abs pairwise structural alignment, see <ext-link ext-link-type="uri" xlink:href="http://nar.oxfordjournals.org/cgi/content/full/gks480/DC1">Supplementary Data S3</ext-link>. (iii) ABRs identification—the ABRs of the query Ab are identified according to the boundaries of the FRs of the top BLAST hit Ab with which it was aligned in the previous step. <xref ref-type="fig" rid="gks480-F2">Figure 2</xref> summarizes the process of ABRs identification.
<fig id="gks480-F2" position="float"><label>Figure 2.</label><caption><p>Antigen-binding regions identification. (<bold>A</bold>) The sequence of the query Ab is BLASTed against the non-redundant set of annotated Abs. (<bold>B</bold>) The framework regions (FRs) of the best BLAST hit Ab are aligned to the query Ab (sequences—BLAST, structures—CE). (<bold>C</bold>) The ABRs of the query Ab are inferred according to the ABRs of the best BLAST hit Ab.</p></caption><graphic xlink:href="gks480f2"/></fig></p>
    </sec>
  </sec>
  <sec>
    <title>PERFORMANCE</title>
    <p>The performance of Paratome has been tested on all Ab–Ag complexes that were added to the PDB after the construction of the training set. For the full list of train and test sets is available at <ext-link ext-link-type="uri" xlink:href="http://ofranservices.biu.ac.il/site/services/paratome/ABRs_train_pdb.txt">http://ofranservices.biu.ac.il/site/services/paratome/ABRs_train_pdb.txt</ext-link>, 23 May 2012, date last accessed <ext-link ext-link-type="uri" xlink:href="http://ofranservices.biu.ac.il/site/services/paratome/ABRs_test_pdb.txt">http://ofranservices.biu.ac.il/site/services/paratome/ABRs_test_pdb.txt</ext-link>, 23 May 2012, date last accessed). A true positive (TP) prediction is a residue that is included in the ABRs and is in contact with the Ag in the experimentally determined structure of the Ab–Ag complex. A true negative (TN) is a residue that is not in the ABR and is not in contact with the Ag. A false positive (FP) is a residue that is in the ABR and not in contact with the Ag in the experimental structure and a false negative (FN) is a residue that is not in the ABR and is in contact with the Ag. The performance was assessed in terms of precision (TP/TP + FP), specificity (TN/TN + FP) and recall (TP/TP + FN). Additionally, performance was compared to that of CDRs, as identified by Kabat, Chothia and IMGT. CDRs according to Kabat and Chothia were obtained by coupling the Abnum tool (<ext-link ext-link-type="uri" xlink:href="http://www.bioinf.org.uk/abs/abnum/">http://www.bioinf.org.uk/abs/abnum/</ext-link>, 23 May 2012, date last accessed) with a table of CDRs definitions (<ext-link ext-link-type="uri" xlink:href="http://www.bioinf.org.uk/abs/#cdrdef">http://www.bioinf.org.uk/abs/#cdrdef</ext-link>, 23 May 2012, date last accessed). To obtain the CDRs according to IMGT, we applied the IMGT-gap tool (<ext-link ext-link-type="uri" xlink:href="http://www.imgt.org/3Dstructure-DB/cgi/DomainGapAlign.cgi">http://www.imgt.org/3Dstructure-DB/cgi/DomainGapAlign.cgi</ext-link>, 23 May 2012, date last accessed). An Ab amino acid and an Ag amino acid were considered as interacting if at least one of their respective atoms were ≤6 Å of each other (<xref ref-type="bibr" rid="gks480-B23">23</xref>). <xref ref-type="table" rid="gks480-T1">Table 1</xref> summarizes the performance obtained by all methods on the test set. While the precision of all methods is roughly the same, the results show that virtually all Ag-binding residues fall within the ABRs predicted by Paratome.
<table-wrap id="gks480-T1" position="float"><label>Table 1.</label><caption><p>Comparative performance of Paratome and the most commonly used CDR identification methods</p></caption><table frame="hsides" rules="groups"><thead align="left"><tr><th rowspan="1" colspan="1">Measure/Method</th><th rowspan="1" colspan="1">Paratome (%)</th><th rowspan="1" colspan="1">Kabat (%)</th><th rowspan="1" colspan="1">Chothia (%)</th><th rowspan="1" colspan="1">IMGT (%)</th></tr></thead><tbody align="left"><tr><td rowspan="1" colspan="1">Recall</td><td rowspan="1" colspan="1">94</td><td rowspan="1" colspan="1">85</td><td rowspan="1" colspan="1">79</td><td rowspan="1" colspan="1">81</td></tr><tr><td rowspan="1" colspan="1">Precision</td><td rowspan="1" colspan="1">42</td><td rowspan="1" colspan="1">41</td><td rowspan="1" colspan="1">44</td><td rowspan="1" colspan="1">48</td></tr><tr><td rowspan="1" colspan="1">Specificity</td><td rowspan="1" colspan="1">83</td><td rowspan="1" colspan="1">85</td><td rowspan="1" colspan="1">89</td><td rowspan="1" colspan="1">91</td></tr></tbody></table><table-wrap-foot><fn id="gks480-TF1"><p>Average precision, recall and specificity were calculated for the Abs in the test set for Paratome, Kabat, Chothia and IMGT methods.</p></fn></table-wrap-foot></table-wrap></p>
  </sec>
  <sec>
    <title>IMPLEMENTATION</title>
    <p>The server was designed and implemented using Perl, bash, Python, HTML, XML and XSL. The front end of the server is designed in HTML, XML and XSL. Structure visualization is enabled using the Jmol Java applet (<ext-link ext-link-type="uri" xlink:href="http://jmol.sourceforge.net/">http://jmol.sourceforge.net/</ext-link>, 23 May 2012, date last accessed). The web server and computations run on a Red-hat Enterprise Linux 5.7 (Tikanga) with 3.00 GHz 8 CPUs and 16 GB primary memory.</p>
  </sec>
  <sec sec-type="conclusions">
    <title>CONCLUSION</title>
    <p>The specificity and affinity of Ab–Ag interactions are fundamental for understanding the biological activity of these molecules. Correct identification of the residues that mediate these interactions is crucial for immunological research and for applications aimed at modifying and manipulating such interactions. Paratome provides a simple interface for the identification of the Ag-binding regions from the amino acid sequence or 3D structure of an Ab and has been shown to do so efficiently. Considering that the 3D structure of most known Abs is yet unknown, the ability to accurately and reliably identify the ABRs directly from sequence, is highly valuable and increases the accessibility of this essential knowledge to the entire scientific community in general and to immunity researchers in particular.</p>
  </sec>
  <sec>
    <title>SUPPLEMENTARY DATA</title>
    <p><ext-link ext-link-type="uri" xlink:href="http://nar.oxfordjournals.org/cgi/content/full/gks480/DC1">Supplementary Data</ext-link> are available at NAR Online: Supplementary Data 1–3.</p>
  </sec>
  <sec>
    <title>FUNDING</title>
    <p>Funding for open access charge: Research grant from the <funding-source>Israel Science Foundation</funding-source> [<award-id>511</award-id>].</p>
    <p><italic>Conflict of interest statement</italic>. None declared.</p>
  </sec>
</body>
<back>
  <ack>
    <title>ACKNOWLEDGEMENTS</title>
    <p>Thanks to Inbal Sela, Anat Burkovitz and Guy Nimrod for their help in testing and feedback on the server and manuscript.</p>
  </ack>
  <ref-list>
    <title>REFERENCES</title>
    <ref id="gks480-B1">
      <label>1</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Chan</surname>
            <given-names>AC</given-names>
          </name>
          <name>
            <surname>Carter</surname>
            <given-names>PJ</given-names>
          </name>
        </person-group>
        <article-title>Therapeutic antibodies for autoimmunity and inflammation</article-title>
        <source>Nat. Rev.</source>
        <year>2010</year>
        <volume>10</volume>
        <fpage>301</fpage>
        <lpage>316</lpage>
      </element-citation>
    </ref>
    <ref id="gks480-B2">
      <label>2</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Verhoeyen</surname>
            <given-names>M</given-names>
          </name>
          <name>
            <surname>Milstein</surname>
            <given-names>C</given-names>
          </name>
          <name>
            <surname>Winter</surname>
            <given-names>G</given-names>
          </name>
        </person-group>
        <article-title>Reshaping human antibodies: grafting an antilysozyme activity</article-title>
        <source>Science</source>
        <year>1988</year>
        <volume>239</volume>
        <fpage>1534</fpage>
        <lpage>1536</lpage>
        <pub-id pub-id-type="pmid">2451287</pub-id>
      </element-citation>
    </ref>
    <ref id="gks480-B3">
      <label>3</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Almagro</surname>
            <given-names>JC</given-names>
          </name>
        </person-group>
        <article-title>Identification of differences in the specificity-determining residues of antibodies that recognize antigens of different size: implications for the rational design of antibody repertoires</article-title>
        <source>J. Mol. Recognit.</source>
        <year>2004</year>
        <volume>17</volume>
        <fpage>132</fpage>
        <lpage>143</lpage>
        <pub-id pub-id-type="pmid">15027033</pub-id>
      </element-citation>
    </ref>
    <ref id="gks480-B4">
      <label>4</label>
      <element-citation publication-type="book">
        <person-group person-group-type="author">
          <name>
            <surname>Lou</surname>
            <given-names>J</given-names>
          </name>
          <name>
            <surname>Marks</surname>
            <given-names>JD</given-names>
          </name>
        </person-group>
        <person-group person-group-type="editor">
          <name>
            <surname>Kontermann</surname>
            <given-names>F</given-names>
          </name>
          <name>
            <surname>Dübel</surname>
            <given-names>S</given-names>
          </name>
        </person-group>
        <article-title>Affinity maturation by chain shuffling and site directed mutagenesis</article-title>
        <source>Antibody Engineering, Part IV</source>
        <year>2010</year>
        <publisher-loc>Springer Berlin Heidelberg</publisher-loc>
        <fpage>377</fpage>
        <lpage>396</lpage>
      </element-citation>
    </ref>
    <ref id="gks480-B5">
      <label>5</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Schrama</surname>
            <given-names>D</given-names>
          </name>
          <name>
            <surname>Reisfeld</surname>
            <given-names>RA</given-names>
          </name>
          <name>
            <surname>Becker</surname>
            <given-names>JC</given-names>
          </name>
        </person-group>
        <article-title>Antibody targeted drugs as cancer therapeutics</article-title>
        <source>Nat. Rev. Drug Discov.</source>
        <year>2006</year>
        <volume>5</volume>
        <fpage>147</fpage>
        <lpage>159</lpage>
        <pub-id pub-id-type="pmid">16424916</pub-id>
      </element-citation>
    </ref>
    <ref id="gks480-B6">
      <label>6</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Hawkins</surname>
            <given-names>RE</given-names>
          </name>
          <name>
            <surname>Russell</surname>
            <given-names>SJ</given-names>
          </name>
          <name>
            <surname>Winter</surname>
            <given-names>G</given-names>
          </name>
        </person-group>
        <article-title>Selection of phage antibodies by binding affinity. Mimicking affinity maturation</article-title>
        <source>J. Mol. Biol.</source>
        <year>1992</year>
        <volume>226</volume>
        <fpage>889</fpage>
        <lpage>896</lpage>
        <pub-id pub-id-type="pmid">1507232</pub-id>
      </element-citation>
    </ref>
    <ref id="gks480-B7">
      <label>7</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Jones</surname>
            <given-names>PT</given-names>
          </name>
          <name>
            <surname>Dear</surname>
            <given-names>PH</given-names>
          </name>
          <name>
            <surname>Foote</surname>
            <given-names>J</given-names>
          </name>
          <name>
            <surname>Neuberger</surname>
            <given-names>MS</given-names>
          </name>
          <name>
            <surname>Winter</surname>
            <given-names>G</given-names>
          </name>
        </person-group>
        <article-title>Replacing the complementarity-determining regions in a human antibody with those from a mouse</article-title>
        <source>Nature</source>
        <year>1986</year>
        <volume>321</volume>
        <fpage>522</fpage>
        <lpage>525</lpage>
        <pub-id pub-id-type="pmid">3713831</pub-id>
      </element-citation>
    </ref>
    <ref id="gks480-B8">
      <label>8</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>MacCallum</surname>
            <given-names>RM</given-names>
          </name>
          <name>
            <surname>Martin</surname>
            <given-names>AC</given-names>
          </name>
          <name>
            <surname>Thornton</surname>
            <given-names>JM</given-names>
          </name>
        </person-group>
        <article-title>Antibody-antigen interactions: contact analysis and binding site topography</article-title>
        <source>J. Mol. Biol.</source>
        <year>1996</year>
        <volume>262</volume>
        <fpage>732</fpage>
        <lpage>745</lpage>
        <pub-id pub-id-type="pmid">8876650</pub-id>
      </element-citation>
    </ref>
    <ref id="gks480-B9">
      <label>9</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Padlan</surname>
            <given-names>EA</given-names>
          </name>
          <name>
            <surname>Abergel</surname>
            <given-names>C</given-names>
          </name>
          <name>
            <surname>Tipper</surname>
            <given-names>JP</given-names>
          </name>
        </person-group>
        <article-title>Identification of specificity-determining residues in antibodies</article-title>
        <source>FASEB J.</source>
        <year>1995</year>
        <volume>9</volume>
        <fpage>133</fpage>
        <lpage>139</lpage>
        <pub-id pub-id-type="pmid">7821752</pub-id>
      </element-citation>
    </ref>
    <ref id="gks480-B10">
      <label>10</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Wu</surname>
            <given-names>TT</given-names>
          </name>
          <name>
            <surname>Kabat</surname>
            <given-names>EA</given-names>
          </name>
        </person-group>
        <article-title>An analysis of the sequences of the variable regions of Bence Jones proteins and myeloma light chains and their implications for antibody complementarity</article-title>
        <source>J. Exp. Med.</source>
        <year>1970</year>
        <volume>132</volume>
        <fpage>211</fpage>
        <lpage>250</lpage>
        <pub-id pub-id-type="pmid">5508247</pub-id>
      </element-citation>
    </ref>
    <ref id="gks480-B11">
      <label>11</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Al-Lazikani</surname>
            <given-names>B</given-names>
          </name>
          <name>
            <surname>Lesk</surname>
            <given-names>AM</given-names>
          </name>
          <name>
            <surname>Chothia</surname>
            <given-names>C</given-names>
          </name>
        </person-group>
        <article-title>Standard conformations for the canonical structures of immunoglobulins</article-title>
        <source>J. Mol. Biol.</source>
        <year>1997</year>
        <volume>273</volume>
        <fpage>927</fpage>
        <lpage>948</lpage>
        <pub-id pub-id-type="pmid">9367782</pub-id>
      </element-citation>
    </ref>
    <ref id="gks480-B12">
      <label>12</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Chothia</surname>
            <given-names>C</given-names>
          </name>
          <name>
            <surname>Lesk</surname>
            <given-names>AM</given-names>
          </name>
        </person-group>
        <article-title>Canonical structures for the hypervariable regions of immunoglobulins</article-title>
        <source>J. Mol. Biol.</source>
        <year>1987</year>
        <volume>196</volume>
        <fpage>901</fpage>
        <lpage>917</lpage>
        <pub-id pub-id-type="pmid">3681981</pub-id>
      </element-citation>
    </ref>
    <ref id="gks480-B13">
      <label>13</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Chothia</surname>
            <given-names>C</given-names>
          </name>
          <name>
            <surname>Lesk</surname>
            <given-names>AM</given-names>
          </name>
          <name>
            <surname>Tramontano</surname>
            <given-names>A</given-names>
          </name>
          <name>
            <surname>Levitt</surname>
            <given-names>M</given-names>
          </name>
          <name>
            <surname>Smith-Gill</surname>
            <given-names>JS</given-names>
          </name>
          <name>
            <surname>Air</surname>
            <given-names>G</given-names>
          </name>
          <name>
            <surname>Sheriff</surname>
            <given-names>S</given-names>
          </name>
          <name>
            <surname>Padlan</surname>
            <given-names>EA</given-names>
          </name>
          <name>
            <surname>Davies</surname>
            <given-names>D</given-names>
          </name>
          <name>
            <surname>Tulip</surname>
            <given-names>WR</given-names>
          </name>
          <etal/>
        </person-group>
        <article-title>Conformations of immunoglobulin hypervariable regions</article-title>
        <source>Nature</source>
        <year>1989</year>
        <volume>342</volume>
        <fpage>877</fpage>
        <lpage>883</lpage>
        <pub-id pub-id-type="pmid">2687698</pub-id>
      </element-citation>
    </ref>
    <ref id="gks480-B14">
      <label>14</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Kabat</surname>
            <given-names>EA</given-names>
          </name>
          <name>
            <surname>Wu</surname>
            <given-names>TT</given-names>
          </name>
          <name>
            <surname>Bilofsky</surname>
            <given-names>H</given-names>
          </name>
        </person-group>
        <article-title>Unusual distributions of amino acids in complementarity-determining (hypervariable) segments of heavy and light chains of immunoglobulins and their possible roles in specificity of antibody-combining sites</article-title>
        <source>J. Biol. Chem.</source>
        <year>1977</year>
        <volume>252</volume>
        <fpage>6609</fpage>
        <lpage>6616</lpage>
        <pub-id pub-id-type="pmid">408353</pub-id>
      </element-citation>
    </ref>
    <ref id="gks480-B15">
      <label>15</label>
      <element-citation publication-type="book">
        <person-group person-group-type="author">
          <name>
            <surname>Kabat</surname>
            <given-names>EA</given-names>
          </name>
          <name>
            <surname>Wu</surname>
            <given-names>TT</given-names>
          </name>
          <name>
            <surname>Bilofsky</surname>
            <given-names>H</given-names>
          </name>
          <name>
            <surname>Reid-Miller</surname>
            <given-names>M</given-names>
          </name>
          <name>
            <surname>Perry</surname>
            <given-names>H</given-names>
          </name>
        </person-group>
        <source>Sequence of Proteins of Immunological Interest</source>
        <year>1983</year>
        <publisher-loc>Bathesda</publisher-loc>
        <publisher-name>National Institute of Health</publisher-name>
      </element-citation>
    </ref>
    <ref id="gks480-B16">
      <label>16</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Lefranc</surname>
            <given-names>MP</given-names>
          </name>
          <name>
            <surname>Pommie</surname>
            <given-names>C</given-names>
          </name>
          <name>
            <surname>Ruiz</surname>
            <given-names>M</given-names>
          </name>
          <name>
            <surname>Giudicelli</surname>
            <given-names>V</given-names>
          </name>
          <name>
            <surname>Foulquier</surname>
            <given-names>E</given-names>
          </name>
          <name>
            <surname>Truong</surname>
            <given-names>L</given-names>
          </name>
          <name>
            <surname>Thouvenin-Contet</surname>
            <given-names>V</given-names>
          </name>
          <name>
            <surname>Lefranc</surname>
            <given-names>G</given-names>
          </name>
        </person-group>
        <article-title>IMGT unique numbering for immunoglobulin and T cell receptor variable domains and Ig superfamily V-like domains</article-title>
        <source>Dev. Comp. Immunol.</source>
        <year>2003</year>
        <volume>27</volume>
        <fpage>55</fpage>
        <lpage>77</lpage>
        <pub-id pub-id-type="pmid">12477501</pub-id>
      </element-citation>
    </ref>
    <ref id="gks480-B17">
      <label>17</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Padlan</surname>
            <given-names>EA</given-names>
          </name>
        </person-group>
        <article-title>Structural implications of sequence variability in immunoglobulins</article-title>
        <source>Proc. Natl Acad. Sci. USA</source>
        <year>1977</year>
        <volume>74</volume>
        <fpage>2551</fpage>
        <lpage>2555</lpage>
        <pub-id pub-id-type="pmid">407580</pub-id>
      </element-citation>
    </ref>
    <ref id="gks480-B18">
      <label>18</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Kunik</surname>
            <given-names>V</given-names>
          </name>
          <name>
            <surname>Peters</surname>
            <given-names>B</given-names>
          </name>
          <name>
            <surname>Ofran</surname>
            <given-names>Y</given-names>
          </name>
        </person-group>
        <article-title>Structural Consensus among Antibodies Defines the Antigen Binding Site</article-title>
        <source>PLoS Comput. Biol.</source>
        <year>2012</year>
        <volume>8</volume>
        <fpage>e1002388</fpage>
        <pub-id pub-id-type="pmid">22383868</pub-id>
      </element-citation>
    </ref>
    <ref id="gks480-B19">
      <label>19</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Ofran</surname>
            <given-names>Y</given-names>
          </name>
          <name>
            <surname>Schlessinger</surname>
            <given-names>A</given-names>
          </name>
          <name>
            <surname>Rost</surname>
            <given-names>B</given-names>
          </name>
        </person-group>
        <article-title>Automated identification of complementarity determining regions (CDRs) reveals peculiar characteristics of CDRs and B cell epitopes</article-title>
        <source>J. Immunol.</source>
        <year>2008</year>
        <volume>181</volume>
        <fpage>6230</fpage>
        <lpage>6235</lpage>
        <pub-id pub-id-type="pmid">18941213</pub-id>
      </element-citation>
    </ref>
    <ref id="gks480-B20">
      <label>20</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Altschul</surname>
            <given-names>SF</given-names>
          </name>
          <name>
            <surname>Madden</surname>
            <given-names>TL</given-names>
          </name>
          <name>
            <surname>Schaffer</surname>
            <given-names>AA</given-names>
          </name>
          <name>
            <surname>Zhang</surname>
            <given-names>J</given-names>
          </name>
          <name>
            <surname>Zhang</surname>
            <given-names>Z</given-names>
          </name>
          <name>
            <surname>Miller</surname>
            <given-names>W</given-names>
          </name>
          <name>
            <surname>Lipman</surname>
            <given-names>DJ</given-names>
          </name>
        </person-group>
        <article-title>Gapped BLAST and PSI-BLAST: a new generation of protein database search programs</article-title>
        <source>Nucleic Acids Res.</source>
        <year>1997</year>
        <volume>25</volume>
        <fpage>3389</fpage>
        <lpage>3402</lpage>
        <pub-id pub-id-type="pmid">9254694</pub-id>
      </element-citation>
    </ref>
    <ref id="gks480-B21">
      <label>21</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Smith</surname>
            <given-names>TF</given-names>
          </name>
          <name>
            <surname>Waterman</surname>
            <given-names>MS</given-names>
          </name>
        </person-group>
        <article-title>Identification of common molecular subsequences</article-title>
        <source>J. Mol. Biol.</source>
        <year>1981</year>
        <volume>147</volume>
        <fpage>195</fpage>
        <lpage>197</lpage>
        <pub-id pub-id-type="pmid">7265238</pub-id>
      </element-citation>
    </ref>
    <ref id="gks480-B22">
      <label>22</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Shindyalov</surname>
            <given-names>IN</given-names>
          </name>
          <name>
            <surname>Bourne</surname>
            <given-names>PE</given-names>
          </name>
        </person-group>
        <article-title>Protein structure alignment by incremental combinatorial extension (CE) of the optimal path</article-title>
        <source>Protein Eng.</source>
        <year>1998</year>
        <volume>11</volume>
        <fpage>739</fpage>
        <lpage>747</lpage>
        <pub-id pub-id-type="pmid">9796821</pub-id>
      </element-citation>
    </ref>
    <ref id="gks480-B23">
      <label>23</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Ofran</surname>
            <given-names>Y</given-names>
          </name>
          <name>
            <surname>Rost</surname>
            <given-names>B</given-names>
          </name>
        </person-group>
        <article-title>Analysing six types of protein-protein interfaces</article-title>
        <source>J. Mol. Biol.</source>
        <year>2003</year>
        <volume>325</volume>
        <fpage>377</fpage>
        <lpage>387</lpage>
        <pub-id pub-id-type="pmid">12488102</pub-id>
      </element-citation>
    </ref>
  </ref-list>
</back>
